Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics

Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children

(2010) James A. MacKenzie et al.   Applied Physiology Nutrition and Metabolism

Relaxin family peptide systems and the central nervous system

(2010) G. E. Callander et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics

(2010) Mehrul Hasnain et al.   Current Diabetes Reports

Metabolic and Neuroendocrine Responses to RXFP3 Modulation in the Central Nervous System

(2009) Steven W. Sutton et al.   Annals of the New York Academy of Sciences

Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients

(2009) D. Clark et al.   EUROPEAN PSYCHIATRY

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Association study of serotonergic gene variants with antipsychotic-induced adverse reactions

(2009) Ismail Al-Janabi et al.   PSYCHIATRIC GENETICS

Developmental expression and serotonergic regulation of relaxin 3/INSL7 in the nucleus incertus of rat brain

(2007) Yasumasa Miyamoto et al.   REGULATORY PEPTIDES